Schilder's Disease

Alpers Syndrome is a rare and severe brain disease that affects children and young adults. It causes progressive brain damage, leading to symptoms like dementia, vision loss, hearing loss, and problems with movement. It also involves liver disease. It's sometimes called Alpers Disease.

Condition

What people with Schilder's Disease report

Every report comes from a Lived member, sent anonymously.

NameHow it went

No reports yet

Add what worked for you with the search bar below

About Schilder's Disease

What It Is

Schilder's disease, also called myelinoclastic diffuse sclerosis, is a rare inflammatory disease of the brain. The immune system damages myelin, the protective coating around nerve fibers, across one or two unusually large areas of white matter deep in the brain. Because those areas carry signals between different parts of the brain, the damage can cause weakness on one side of the body, vision loss, problems with speech, thinking or behavior, headache with vomiting, and sometimes seizures. It mostly affects children and young people, and symptoms usually develop over days to weeks. Schilder's disease belongs to the same broad family as multiple sclerosis (MS), and it was long described as a variant of MS. More recent research suggests that in most people it is a separate condition: MS usually causes many small patches of damage over years, while Schilder's disease typically causes one or two large ones, often as a single episode. The name is sometimes filed alongside Baló concentric sclerosis and Alpers syndrome, but those are different diseases.

Causes & Risk Factors

The cause of Schilder's disease is not known. It is considered an autoimmune, inflammatory process, meaning the body's own immune response attacks myelin, but researchers have not identified what sets it off or who is at risk. Unlike a related condition called acute disseminated encephalomyelitis (ADEM), it does not usually follow a recent viral illness or vaccination. Some early cases labeled Schilder's disease turned out to be adrenoleukodystrophy, an inherited metabolic disorder that also damages white matter. That is one reason the diagnosis is made only after other causes have been ruled out.

How It's Diagnosed

There is no single test for Schilder's disease. Diagnosis usually starts with a magnetic resonance imaging (MRI) scan of the brain, which shows the large areas of white matter damage. These areas can swell and look like a brain tumor or abscess, so specialists use additional MRI techniques, the pattern of the lesions and how they change over time to tell them apart. When imaging cannot settle the question, a small sample of brain tissue (a biopsy) may be taken. A biopsy can be decisive but is not always conclusive and carries risks such as bleeding, so avoiding an unnecessary one is a real goal. Other tests help rule out conditions that look similar. Blood tests for very long-chain fatty acids and adrenal gland function check for adrenoleukodystrophy. A lumbar puncture (spinal tap) collects spinal fluid; in MS this fluid usually contains oligoclonal bands, a sign of antibody production inside the nervous system, while most people with Schilder's disease do not have them. Doctors may also test the blood for antibodies against myelin oligodendrocyte glycoprotein (MOG) or aquaporin-4, which point to related conditions called MOG antibody-associated disease and neuromyelitis optica, and check for infections.

Treatment Options

Because Schilder's disease is so rare, there are no clinical trials and no proven treatment. Care is based on case reports and on experience with similar inflammatory conditions. The usual first treatment is a high dose of corticosteroids (steroids that calm inflammation), often given through a vein for several days and then tapered by mouth over weeks to months. Many reported patients improved markedly, and lesions shrank on follow-up scans, although some kept lasting weakness or other deficits. When steroids are not enough, doctors may consider other immune treatments such as plasma exchange, intravenous immunoglobulin (IVIG, antibodies pooled from donors) or rituximab, a drug that depletes antibody-producing B cells; these have been used in only a handful of people, so their benefit is uncertain. For someone who relapses or whose illness starts to look more like MS, long-term MS medicines may be considered. Rehabilitation, including physical, occupational and speech therapy, helps people regain function, and medicines may be needed for seizures or muscle stiffness.

What to Expect

The course varies widely. Many people have a single episode, and with treatment some recover fully or nearly fully, while others are left with weakness, vision problems or difficulties with thinking. Some people have further attacks, and a few later develop a pattern that meets the criteria for MS. Severe cases can progress quickly, and before modern treatment the disease was sometimes fatal. Recovery often continues for months after the acute illness, and rehabilitation plays a large part. Follow-up visits with a neurologist and repeat MRI scans track whether the lesions are healing and whether new ones appear. For children, school support and regular reassessment of learning, vision and movement can help as they grow.

When to Seek Help

See a doctor promptly about weakness, vision changes, trouble speaking, or changes in thinking or behavior that develop over days or weeks, especially in a child or young adult. For someone already diagnosed, new or worsening weakness, loss of vision, or a severe headache with repeated vomiting needs same-day medical assessment, since it can mean a new attack or increasing swelling in the brain. Call 911 if the person becomes very drowsy or hard to wake, or has a seizure that lasts longer than 5 minutes or repeated seizures without waking up in between.

Questions to Ask Your Doctor

  1. 1.What other conditions could explain these MRI findings, and which tests will we use to rule them out?
  2. 2.Is a brain biopsy needed, or can the diagnosis be made without one?
  3. 3.What are the realistic benefits and side effects of the steroid treatment, and what happens if it does not work?
  4. 4.How will we monitor for relapse or for signs that this is turning out to be MS?
  5. 5.What rehabilitation and school or work support would help recovery?

Last reviewed • Oct 2026

Educational content, not medical advice.